Administration Finalizes Medicare Part B International Reference Pricing Model Rachel SachsandKristi Martin October 22, 2026

https://www.healthaffairs.org/content/forefront/administration-finalizes-medicare-part-b-international-reference-pricing-model?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-9Ge-_yY_BxNkFnbuOgVMq0S53Add8fwtsQVnezB3cNY0qqUW7PsxL-eePgn9c6IlP5mb5Q1e7O4qOb-6tsltkTEBjZGQ&_hsmi=445751573&utm_source=hasu Through new categorical drug exclusions and a manufacturer-level exemption for companies participating in GENEROUS, CMS has narrowed GLOBE to an estimated 3 percent of eligible Part B drug spending and four or perhaps even fewer manufacturers.